Report error Found 1147 with Last Name = 'nakaya' and Initial = 'k'
Affinity DataKi: 1.00E+3nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 1.90E+3nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 2.00E+3nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 3.80E+3nMAssay Description:Binding affinity to human recombinant DDOMore data for this Ligand-Target Pair
Affinity DataKi: 5.89E+3nMAssay Description:Inhibition of rat recombinant DDO using D-AspMore data for this Ligand-Target Pair
Affinity DataKi: 6.00E+3nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 8.00E+3nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 8.69E+3nMAssay Description:Inhibition of mouse recombinant DDO using D-AspMore data for this Ligand-Target Pair
Affinity DataKi: 9.00E+3nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 1.10E+4nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 1.40E+4nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 1.51E+4nMAssay Description:Binding affinity to human recombinant DDOMore data for this Ligand-Target Pair
Affinity DataKi: 1.60E+4nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 2.20E+4nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 2.40E+4nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 3.26E+4nMAssay Description:Inhibition of mouse recombinant DDO using D-AspMore data for this Ligand-Target Pair
Affinity DataKi: 4.50E+4nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 4.50E+4nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 5.00E+4nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 5.30E+4nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 6.59E+4nMAssay Description:Inhibition of rat recombinant DDO using D-AspMore data for this Ligand-Target Pair
Affinity DataKi: 7.20E+4nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 1.47E+5nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 1.53E+5nMAssay Description:Binding affinity to human recombinant DDOMore data for this Ligand-Target Pair
Affinity DataKi: 5.83E+5nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataKi: 1.22E+6nMAssay Description:Inhibition of mouse recombinant DDO using D-AspMore data for this Ligand-Target Pair
Affinity DataKi: 1.56E+6nMAssay Description:Inhibition of rat recombinant DDO using D-AspMore data for this Ligand-Target Pair
Affinity DataKi: 1.59E+6nMAssay Description:Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometryMore data for this Ligand-Target Pair
Affinity DataIC50: 0.100nMAssay Description:Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spect...More data for this Ligand-Target Pair
Affinity DataIC50: 0.200nMAssay Description:Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spect...More data for this Ligand-Target Pair
Affinity DataIC50: 0.200nMAssay Description:Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spect...More data for this Ligand-Target Pair
Affinity DataIC50: 0.370nMAssay Description:Enzyme assay using full length recombinant active form of wild-type BTK and BTK-C481S was measured as described previously (Anastassiadis T, et al., ...More data for this Ligand-Target Pair
Affinity DataIC50: 0.390nMAssay Description:Enzyme assay using full length recombinant active form of wild-type BTK and BTK-C481S was measured as described previously (Anastassiadis T, et al., ...More data for this Ligand-Target Pair
Affinity DataIC50: 0.400nMAssay Description:Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spect...More data for this Ligand-Target Pair
Affinity DataIC50: 0.490nMAssay Description:Inhibition of recombinant N-terminal His-tagged human FER (SH2 domain to C-terminal) expressed in Escherichia coli assessed as decrease in FL-Peptide...More data for this Ligand-Target Pair
Affinity DataIC50: 0.5nMAssay Description:Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spect...More data for this Ligand-Target Pair
Affinity DataIC50: 0.560nMAssay Description:Enzyme assay using full length recombinant active form of wild-type BTK and BTK-C481S was measured as described previously (Anastassiadis T, et al., ...More data for this Ligand-Target Pair
Affinity DataIC50: 0.560nMAssay Description:Enzyme assay using full length recombinant active form of wild-type BTK and BTK-C481S was measured as described previously (Anastassiadis T, et al., ...More data for this Ligand-Target Pair
Affinity DataIC50: 0.770nMAssay Description:Full length unphosphorylated form of BTK expressed in Sf9 cells was employed to test inhibitory activity in the inactive BTK assay. The assay was mea...More data for this Ligand-Target Pair
Affinity DataIC50: 0.790nMAssay Description:Enzyme assay using full length recombinant active form of wild-type BTK and BTK-C481S was measured as described previously (Anastassiadis T, et al., ...More data for this Ligand-Target Pair
Affinity DataIC50: 0.800nMAssay Description:Inhibition of human SGLT2 expressed in CHOK cells assessed as reduction of [14C]alpha-methyl-D-glucopyranoside uptake after 120 mins by liquid scinti...More data for this Ligand-Target Pair
Affinity DataIC50: 0.800nMAssay Description:Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spect...More data for this Ligand-Target Pair
Affinity DataIC50: 0.850nMAssay Description:Enzyme assay using full length recombinant active form of wild-type BTK and BTK-C481S was measured as described previously (Anastassiadis T, et al., ...More data for this Ligand-Target Pair
Affinity DataIC50: 0.850nMAssay Description:Enzyme assay using full length recombinant active form of wild-type BTK and BTK-C481S was measured as described previously (Anastassiadis T, et al., ...More data for this Ligand-Target Pair
Affinity DataIC50: 0.930nMAssay Description:Full length unphosphorylated form of BTK expressed in Sf9 cells was employed to test inhibitory activity in the inactive BTK assay. The assay was mea...More data for this Ligand-Target Pair
Affinity DataIC50: 0.980nMAssay Description:Purified full-length inactive BTK (wild type and C481 mutant, N-terminal 6XHIS tagged BTK, Mwt=78.2 kDa) were activated using soluble inositol hexaki...More data for this Ligand-Target Pair
Affinity DataIC50: 0.980nMAssay Description:Purified full-length inactive BTK (wild type and C481 mutant, N-terminal 6XHIS tagged BTK, Mwt=78.2 kDa) were activated using soluble inositol hexaki...More data for this Ligand-Target Pair
Affinity DataIC50: 0.980nMAssay Description:The active BTK assay consisted of phosphorylated form of full length BTK. The assay was performed in a buffer solution utilized in the inactive BTK a...More data for this Ligand-Target Pair
Affinity DataIC50: 0.980nMAssay Description:Purified full-length inactive BTK (wild type and C481 mutant, N-terminal 6XHIS tagged BTK, Mwt=78.2 kDa) were activated using soluble inositol hexaki...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:The active BTK assay consisted of phosphorylated form of full length BTK. The assay was performed in a buffer solution utilized in the inactive BTK a...More data for this Ligand-Target Pair